Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henriette Farkas
Lilian Varga

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
The Hungarian HAE experienceHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|May 19, 2010
Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitorLilian Varga, Henriette Farkas
Biologics in Therapy|February 4, 2014
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|March 24, 2011
rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiencyLilian Varga, Henriette Farkas
Clinical, Cosmetic and Investigational Dermatology|July 16, 2011
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyHenriette Farkas, Lilian Varga
Molecular Immunology|December 7, 2011
Strong correlation of high EBNA-1-IgG levels with edematous attacks involving upper airway mucosa in hereditary angioedema due to C1-inhibitor deficiencyDorottya Csuka, Lilian Varga, Henriette Farkas, et al.
Clinical Immunology (Orlando, Fla.)|February 9, 2011
Parameters of the classical complement pathway predict disease severity in hereditary angioedemaDorottya Csuka, George Füst, Henriette Farkas, et al.
Molecular Immunology|November 30, 2010
Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedemaLilian Varga, George Füst, Dorottya Csuka, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 30, 2002
Clinical management of hereditary angio-oedema in childrenHenriette Farkas, George Harmat, George Füst, et al.
Heliyon|November 17, 2022
Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiencyZsofia Polai, Zsuzsanna Balla, Lilian Varga, et al.
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
The Hungarian HAE experienceHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|May 19, 2010
Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitorLilian Varga, Henriette Farkas
Biologics in Therapy|February 4, 2014
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor DeficiencyHenriette Farkas, Lilian Varga
Expert Review of Clinical Immunology|March 24, 2011
rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiencyLilian Varga, Henriette Farkas
Clinical, Cosmetic and Investigational Dermatology|July 16, 2011
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyHenriette Farkas, Lilian Varga
Molecular Immunology|December 7, 2011
Strong correlation of high EBNA-1-IgG levels with edematous attacks involving upper airway mucosa in hereditary angioedema due to C1-inhibitor deficiencyDorottya Csuka, Lilian Varga, Henriette Farkas, et al.
Clinical Immunology (Orlando, Fla.)|February 9, 2011
Parameters of the classical complement pathway predict disease severity in hereditary angioedemaDorottya Csuka, George Füst, Henriette Farkas, et al.
Molecular Immunology|November 30, 2010
Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedemaLilian Varga, George Füst, Dorottya Csuka, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 30, 2002
Clinical management of hereditary angio-oedema in childrenHenriette Farkas, George Harmat, George Füst, et al.
Heliyon|November 17, 2022
Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiencyZsofia Polai, Zsuzsanna Balla, Lilian Varga, et al.
Pageof 21